These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Renal phenotypes correlate with genotypes in unrelated individuals with tuberous sclerosis complex in China. Luo C; Zhang Y; Zhang YS; Zhang MX; Ning J; Chen MF; Li Y; Qi L; Zu XB; Li YL; Cai Y Orphanet J Rare Dis; 2022 Jul; 17(1):288. PubMed ID: 35870981 [TBL] [Abstract][Full Text] [Related]
24. Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma. Gupta S; Stanton ML; Reynolds JP; Whaley RD; Herrera-Hernandez L; Jimenez RE; Cheville JC Hum Pathol; 2022 Nov; 129():123-139. PubMed ID: 36115585 [TBL] [Abstract][Full Text] [Related]
25. Germline mutation of TSC1 or TSC2 gene in Chinese patients with bilateral renal angiomyolipomas and mutation spectrum of Chinese TSC patients. Jiangyi W; Gang G; Guohai S; Dingwei Y Aging (Albany NY); 2020 Jan; 12(1):756-766. PubMed ID: 31927531 [TBL] [Abstract][Full Text] [Related]
26. He J; Zhou W; Shi J; Lin J; Zhang B; Sun Z Genet Test Mol Biomarkers; 2020 Jan; 24(1):1-5. PubMed ID: 31855466 [No Abstract] [Full Text] [Related]
27. Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex. Rosengren T; Nanhoe S; de Almeida LGD; Schönewolf-Greulich B; Larsen LJ; Hey CAB; Dunø M; Ek J; Risom L; Nellist M; Møller LB Sci Rep; 2020 Jun; 10(1):9909. PubMed ID: 32555378 [TBL] [Abstract][Full Text] [Related]
28. Malignant tumors in tuberous sclerosis complex: a case report and review of the literature. Liu C; Lele SM; Goodenberger MH; Reiser GM; Christiansen AJ; Padussis JC BMC Med Genomics; 2024 May; 17(1):144. PubMed ID: 38802873 [TBL] [Abstract][Full Text] [Related]
29. Detection of TSC1/TSC2 mosaic variants in patients with cardiac rhabdomyoma and tuberous sclerosis complex by hybrid-capture next-generation sequencing. Wang S; Sun H; Wang J; Gu X; Han L; Wu Y; Yan H; Han L; Zhang H; He Y Mol Genet Genomic Med; 2021 Oct; 9(10):e1802. PubMed ID: 34480426 [TBL] [Abstract][Full Text] [Related]
30. Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database. Boggarapu S; Roberds SL; Nakagawa J; Beresford E Orphanet J Rare Dis; 2022 Sep; 17(1):355. PubMed ID: 36104799 [TBL] [Abstract][Full Text] [Related]
31. A novel de novo mutation in the TSC2 gene in a Chinese patient with tuberous sclerosis complex. Li W; Zhou P; Zhao C; Zhang Y J Neurogenet; 2016; 30(3-4):285-287. PubMed ID: 27776463 [TBL] [Abstract][Full Text] [Related]
32. Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events. Qin W; Chan JA; Vinters HV; Mathern GW; Franz DN; Taillon BE; Bouffard P; Kwiatkowski DJ Brain Pathol; 2010 Nov; 20(6):1096-105. PubMed ID: 20633017 [TBL] [Abstract][Full Text] [Related]
33. Mutation landscape of TSC1/TSC2 in Chinese patients with tuberous sclerosis complex. Meng Y; Yu C; Chen M; Yu X; Sun M; Yan H; Zhao W; Yu S J Hum Genet; 2021 Mar; 66(3):227-236. PubMed ID: 32917966 [TBL] [Abstract][Full Text] [Related]
34. Renal disease in tuberous sclerosis complex: pathogenesis and therapy. Lam HC; Siroky BJ; Henske EP Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive Genetic Analysis Results of TSC1/TSC2 Genes in Patients with Clinical Suspicion of Tuberous Sclerosis Complex and Definition of 3 Novel Variants. Demir S; Yalçıntepe S; Atlı E; Yalçın Y; İkbal Atlı E; Eker D; Karal Y; Gürkan H Balkan Med J; 2021 Nov; 38(6):341-347. PubMed ID: 34860161 [TBL] [Abstract][Full Text] [Related]
36. Identification of TSC2 mosaic mutation limited to cortical tuber with TSC targeted sequencing: a case report and literature review. Zhou Y; Wang X; Wang J; Ding Y; Wang Y; Li H; Zhao R; Wu B Childs Nerv Syst; 2021 Dec; 37(12):3945-3949. PubMed ID: 33517515 [TBL] [Abstract][Full Text] [Related]
37. Establishment of human induced pluripotent stem cell lines, KMUGMCi006, from a patient with Tuberous sclerosis complex (TSC) bearing mosaic nonsense mutations in the Tuberous sclerosis complex 2 (TSC2) gene. Ura H; Togi S; Ozaki M; Hatanaka H; Niida Y Stem Cell Res; 2023 Aug; 70():103129. PubMed ID: 37271041 [TBL] [Abstract][Full Text] [Related]
38. Genetics, genomics, and genotype-phenotype correlations of TSC: Insights for clinical practice. Peron A; Au KS; Northrup H Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):281-290. PubMed ID: 30255984 [TBL] [Abstract][Full Text] [Related]
39. Distinct clinical characteristics of tuberous sclerosis complex patients with no mutation identified. Camposano SE; Greenberg E; Kwiatkowski DJ; Thiele EA Ann Hum Genet; 2009 Mar; 73(2):141-6. PubMed ID: 19133941 [TBL] [Abstract][Full Text] [Related]
40. Mutational analysis of TSC1 and TSC2 in Japanese patients with tuberous sclerosis complex revealed higher incidence of TSC1 patients than previously reported. Niida Y; Wakisaka A; Tsuji T; Yamada H; Kuroda M; Mitani Y; Okumura A; Yokoi A J Hum Genet; 2013 Apr; 58(4):216-25. PubMed ID: 23389244 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]